Systematic review of the use of pheromones for treatment of undesirable behavior in cats and dogs

Journal of the American Veterinary Medical Association

Volumn 236, Issue 12, 2010, Pages 1308-1316

  Frank, Diane ^a   Beauchamp, Guy ^a   Palestrini, Clara ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PHEROMONE;

ANIMAL; ANIMAL BEHAVIOR; ANIMAL HUSBANDRY; CAT; DOG; DRUG EFFECT; REVIEW;

ANIMAL HUSBANDRY; ANIMALS; BEHAVIOR, ANIMAL; CATS; DOGS; PHEROMONES;

EID: 77954686512     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.236.12.1308     Document Type: Article

References (35)

1. Stowers L, Marton TF. What is a pheromone? Mammalian pheromones reconsidered. Neuron 2005;46:699-702.
2. Leinders-Zufall T, Lane AP, Puche AC, et al. Ultrasensitive pheromone detection by mammalian vomeronasal neurons. Nature 2000;405:792-796.
3. Lin DY, Zhang SZ, Block E, et al. Encoding social signals in the mouse main olfactory bulb. Nature 2005;434:470-477.
4. Dorries KM, Adkins-Regan E, Halpern BP. Sensitivity and behavioral responses to the pheromone androstenone are not mediated by the vomeronasal organ in domestic pigs. Brain Behav Evol 1997;49:53-62.
5. Buck L, Axel R. A novel multigene family may encode odorant receptors: a molecular basis for odor recognition. Cell 2004;65:175-187.
6. Baum KA. Introduction to the special issue on olfaction, sex, and behavior. Horm Behav 2004;46:217-218.
7. Sam M, Vora S, Malinc B, et al. Odorants may arouse instinctive behaviours. Nature 2001;412:142.
8. Tucker AO, Tucker SS. Catnip and the catnip response. Econ Bot 1988;42:214-231.
9. Gaultier E, Bonnafous L, Bougrat L, et al. Comparison of the efficacy of a dog-appeasing pheromone with clomipramine for the treatment of separation related disorders in dogs. Vet Rec 2005;156:533-538.
10. Gaultier E, Bonnafous L, Vienet-Legué D, et al. Efficacy of dogappeasing pheromone in reducing stress associated with social isolation in newly adopted puppies. Vet Rec 2008;163:73-80.
11. Mills DS, White JC. Long-term follow up of the effect of a pheromone therapy on feline spraying behaviour. Vet Rec 2000;147:746-747.
12. Olivry T, Mueller RS. Evidence based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitis. Vet Dermatol 2003;14:121-146.
13. Schulz KF, Grimes DA. Generation of allocation sequences in randomised trials: chance not choice. Lancet 2002;359:515-519.
14. Schulz KF, Grimes DA. Allocation concealment in randomised trials: defending against deciphering. Lancet 2002;359:614-618.
15. SUNY Downstate Medical Center. Guide to research methods: the evidence pyramid. Available at: www.downstate.edu/EBM2/ 2100htm. Accessed Apr 7, 2010.
16. Tod E, Brander D, Waran N. Efficacy of dog appeasing pheromone in reducing stress and fear related behaviour in shelter dogs. Appl Anim Behav Sci 2005;93:295-308.
17. Frank D, Erb HN, Houpt KA. Urine spraying in cats: presence of concurrent disease and effects of a pheromone treatment. Appl Anim Behav Sci 1999;61:263-272.
18. Hunthausen W. Evaluating a feline facial pheromone analogue to control urine spraying. Vet Med (Praha) 2000;95:151-155.
19. Mills DS, Mills CB. Evaluation of a novel method for delivering a synthetic analogue of feline facial pheromone to control urine spraying by cats. Vet Rec 2001;149:197-199.
20. Ogata N, Takeuchi Y. Clinical trial of a feline pheromone analogue for feline urine marking. J Vet Med Sci 2001;63:157-161.
21. Gunn-Moore DA, Cameron ME. A pilot study using synthetic feline facial pheromone for the management of feline idiopathic cystitis. J Feline Med Surg 2004;6:133-138.
22. Kronen PW, Ludders JW, Hollis NE, et al. A synthetic fraction of feline facial pheromones calms but does not reduce struggling in cats before venous catheterization. Vet Anaesth Analg 2006;33:258-265.
23. Griffith CA, Steigerwald ES, Buffington CAT. Effects of a synthetic facial pheromone on behavior of cats. J Am Vet Med Assoc 2000;217:1154-1156.
24. Sheppard G, Mills DS. Evaluation of dog-appeasing pheromone as a potential treatment for dogs fearful of fireworks. Vet Rec 2003;152:432-436.
25. Levine ED, Ramos D, Mills DS. A prospective study of two self-help CD based desensitization and counter-conditioning programmes with the use of dog appeasing pheromone for the treatment of firework fears in dogs (Canis familiaris). Appl Anim Behav Sci 2007;105:311-329.
26. Gandia Estellés M, Mills DS. Signs of travel-related problems in dogs and their response to treatment with dog-appeasing pheromone. Vet Rec 2006;159:143-148.
27. Mills DS, Ramos D, Gandia Estellés M, et al. A triple blind placebo-controlled investigation into the assessment of the effect of dog appeasing pheromone (DAP) on anxiety related behaviour of problem dogs in the veterinary clinic. Appl Anim Behav Sci 2006;98:114-126.
28. Taylor K, Mills DS. A placebo-controlled study to investigate the effect of dog appeasing pheromone and other environmental factors on the reports of disturbance and house soiling during the night in recently adopted puppies (Canis familiaris). Appl Anim Behav Sci 2007;105:358-368.
29. Denenberg S, Landsberg GM. Effects of dog-appeasing pheromones on anxiety and fear in puppies during training and on long-term socialization. J Am Vet Med Assoc 2008;233:1874-1882.
30. Jüni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001;323:42-46.
31. Altman DG. Randomisation. Essential for reducing bias. BMJ 1999;302:1481-1482.
32. Yuan C, Mehendale S, Xiao Y, et al. The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity. Anesth Analg 2004;98:353-358.
33. Schwartz S. Psychoactive herbs in veterinary behavior medicine. Ames, Iowa: Blackwell Publishing, 2005;76-86.
34. Keene BW. Towards evidence-based veterinary medicine. J Vet Intern Med 2000;14:118-119.
35. Feliway Pheromone Spray brochure. Phoenix: Veterinary Products Laboratories, 2001.